Discover and read the best of Twitter Threads about #chemo
Most recents (8)
TW: my thread here talks about #Cancer #chemotherapy #Grief #Loss #COVID19 #forgotten500k #ClinicallyVulnerable if any of these topics are painful for you, this might not be a helpful thread to read. 🙏🏼 please sign this petition asking for #MasksInHealthcare
🧵 1/
Two years ago my mum died in hospital from v rare #chemo complications Bcs of covid rules we hadn’t been able to see her during her 3 wk hospital stay apart from briefly in her last 48 hrs on compassionate grounds. We had just come out of the horrific winter20/1 wave
Two years ago my mum died in hospital from v rare #chemo complications Bcs of covid rules we hadn’t been able to see her during her 3 wk hospital stay apart from briefly in her last 48 hrs on compassionate grounds. We had just come out of the horrific winter20/1 wave
2/Of course I wanted to see my mum prior to that though initially the gravity of her symptoms weren’t known. I WANTED her to be on a ward with restricted visits & mask mandates bcs I appreciated she & other patients on the oncology ward were very vulnerable…
I am raising money for 4 #Yemeni kids suffering from cancer after being injured in a air-force bombing. Please help by donating & sharing the link. They need #Chemotherapy & housing. gofund.me/718d64e5
This is Mohamed & his sister Aminah and his older brother Naser. Lets all chip in and help please. My DM is now open to contact me. 
Mohamed,9, is the youngest of the siblings and he will be receiving #chemo this weekend. We need to raise a minimum of $1300 just for that. #Yemen #ImpossibleIsNothing
#PatientCentric care, #PtExperience #Tokenism, #HoldingSpace #WeAreBetterTogether ⚠️ long thread.
Recently I attended a meeting of an organization whose focus is in improving #healthcare. This is a highly respected organization. One ☝🏼 of their founding principles is the 1/
Recently I attended a meeting of an organization whose focus is in improving #healthcare. This is a highly respected organization. One ☝🏼 of their founding principles is the 1/
engagement of various #stakeholders including #patients and #caregivers. This was not the 1st meeting of this org. I have attended. I walked away from this particular meeting sad, frustrated & a bit angry. The topic was on #patientcentric care. A topic that is near & dear 2/
to me. The caliber of individuals involved was spectacular; academics, researchers, consultants. As I scrolled through participants as well as listened to the conversation and watched the comments come across the screen I was enthralled with the dialogue however 3/
I gotta vent! Chemo is scary af! I have to flush the toilet twice and preferably use a separate bathroom to keep the Chemo from other people. I can't have sex for 72 hours after infusion because my vagina can leak Chemo after infusion. Terrifying!
All of my clothes that I wore to my infusion and 72 hours after infusion I have to be washed separately from other people laundry. I can't share towels or anything for that matter. If my hubs comes in contact with my body fluids during this time he has to wash and flush...
the area that may have been contaminated. Signs he's been effected are a rash or worse. I'm toxic during that time for three days out of the week. It's scary. It's working as far as we can tell but it's scary!
#chemotherapy #Chemo #breastcancer #ActuallyAutistic
#chemotherapy #Chemo #breastcancer #ActuallyAutistic
Folks! We return for #HOTrainees with the exciting #Day2 @myESMO #ESMO20 and some more #practice relevant studies in #breastcancer #ProstateCancer #lungcancer #GI, so sit back, relax and lets go through some data (#HO #trainee-style!) Shout out to @peters_solange @OncoAlert
1. #BreastCancer: We have #monarchE and #IMPassion031 hoping to hear from experts @ErikaHamilton9 @NicoleKuderer @DrSGraff @matteolambe @tmprowell @GeorgeSledge51 @VukovicPetra for more insights- please link to your discussions here for #trainees:
1. A) #monarchE: use of #abemiciclib in HR+, HER2-,high risk #EBC in addition to endocrine therapy.
Current #SOC: adjuvant ET (5-10 years)
#monarchE: #Abemaciclib + ET iDFS HR 0.747, here's a great summary by @ErikaHamilton9 for @OncoAlert :
Current #SOC: adjuvant ET (5-10 years)
#monarchE: #Abemaciclib + ET iDFS HR 0.747, here's a great summary by @ErikaHamilton9 for @OncoAlert :
@myESMO #ESMO20 as a #trainee can be #overwhelming! So many good studies, some more #practicechanging then others, if you missed some and want to understand (albeit at a simplistic #trainee level), sit back, relax and enjoy as we go through some great data #ESMO20 @OncoAlert
1. #NSCLC: 2 major studies #ADAURA #CROWN for adjuvant #EGFRmNSCLC, and advanced #ALK+ experts can provide better perspective @JackWestMD @n8pennell @StephenVLiu @AMansfieldMD @CharuAggarwalMD @NarjustDumaMD @GlopesMd @DevikaDasMD @OncoAlert
1. A) #ADAURA: Stage IB-IIIA #resected #NSCLC with #EGFRm treated with #Osimertinib vs #placebo [SOC prior to this was adjuvant chemotherapy [cisplatin-based doublet based on #LACE metanalysis- pubmed.ncbi.nlm.nih.gov/18506026/] showed improvement in #DFS @NEJM nejm.org/doi/full/10.10…
Truly grateful to announce I have been promoted to Associate Professor at @MonashBiol 😊
I would like to thank my team & former team members, my collaborators, mentors, colleagues for the support and feedback @BBM_Wong and @RobertB_R, & my boss @OBryanMoira for the push to apply
I would like to thank my team & former team members, my collaborators, mentors, colleagues for the support and feedback @BBM_Wong and @RobertB_R, & my boss @OBryanMoira for the push to apply
Inspired by @jane_bourke_phd I would like to share how I got here because I look up to many & constantly think I am not doing 'well' enough. What I learned over the years is that on paper things look much more glamorous than they are (I call it the Instagram of academia) 1/
I came from a developing country (#Brazil) where research is not valued and there is little $ available. But I had amazing lecturers and teachers, and amazing opportunities to do research since I was an undergrad. This resulted in 5 papers prior to my PhD & helped me a lot 2/
Thanks to all my colleagues for voting. This is an interesting question in breast oncology, and practice varies quite a bit (As you can see from the poll)
#medtwitter #breastcancer #OncoAlert #chemo #courtingcontroversy
#oncology
#tweetorial
Thread
1/6
#medtwitter #breastcancer #OncoAlert #chemo #courtingcontroversy
#oncology
#tweetorial
Thread
1/6
There is interest in getting rid of anthracyclines from adjuvant chemotherapy of breast cancer, due to long-term concerns of heart failure and secondary leukemia. The ABC meta-analysis seemed to concur that taxane+anthracycline (TaxAC) beats 6TC by a small margin
2/6
2/6
An unplanned subgroup analysis revealed interaction with number of nodes in HR+ patients, with no benefit in HR+ N0 disease.
3/6
3/6
